Cytoplasmic functions of the tumour suppressor p53.

PubWeight™: 5.23‹?› | Rank: Top 1%

🔗 View Article (PMC 2814168)

Published in Nature on April 30, 2009

Authors

Douglas R Green1, Guido Kroemer

Author Affiliations

1: Department of Immunology, St Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. douglas.green@stjude.org

Articles citing this

(truncated to the top 100)

Autophagy and the integrated stress response. Mol Cell (2010) 11.21

The first 30 years of p53: growing ever more complex. Nat Rev Cancer (2009) 8.00

Distinct p53 transcriptional programs dictate acute DNA-damage responses and tumor suppression. Cell (2011) 4.74

p53 opens the mitochondrial permeability transition pore to trigger necrosis. Cell (2012) 4.11

p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase. Nat Cell Biol (2011) 3.70

AID produces DNA double-strand breaks in non-Ig genes and mature B cell lymphomas with reciprocal chromosome translocations. Mol Cell (2009) 2.75

p53 post-translational modification: deregulated in tumorigenesis. Trends Mol Med (2010) 2.54

When NRF2 talks, who's listening? Antioxid Redox Signal (2010) 2.32

Protein-based human iPS cells efficiently generate functional dopamine neurons and can treat a rat model of Parkinson disease. J Clin Invest (2011) 2.23

Tumor suppressive functions of p53. Cold Spring Harb Perspect Biol (2009) 2.10

Metabolic regulation by p53 family members. Cell Metab (2013) 2.00

Cell biology. Metabolic control of cell death. Science (2014) 1.98

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance. Proc Natl Acad Sci U S A (2011) 1.97

Oxidative stress in ischemic brain damage: mechanisms of cell death and potential molecular targets for neuroprotection. Antioxid Redox Signal (2011) 1.96

p53 at a glance. J Cell Sci (2010) 1.88

Linking ER Stress to Autophagy: Potential Implications for Cancer Therapy. Int J Cell Biol (2010) 1.86

High mitochondrial priming sensitizes hESCs to DNA-damage-induced apoptosis. Cell Stem Cell (2013) 1.86

Inhibition of mitochondrial fragmentation diminishes Huntington's disease-associated neurodegeneration. J Clin Invest (2013) 1.83

Apoptosis and oncogenesis: give and take in the BCL-2 family. Curr Opin Genet Dev (2011) 1.71

Many players in BCL-2 family affairs. Trends Biochem Sci (2014) 1.64

Endocytosis and signaling: cell logistics shape the eukaryotic cell plan. Physiol Rev (2012) 1.61

Reciprocal influence of the p53 and the hypoxic pathways. Cell Death Dis (2011) 1.60

Autophagy mediates pharmacological lifespan extension by spermidine and resveratrol. Aging (Albany NY) (2009) 1.48

Autophagy genes as tumor suppressors. Curr Opin Cell Biol (2009) 1.44

Janus-faced role of SIRT1 in tumorigenesis. Ann N Y Acad Sci (2012) 1.43

p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Res (2012) 1.41

Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta (2011) 1.40

Regulation of autophagy in mammals and its interplay with apoptosis. Cell Mol Life Sci (2010) 1.40

Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer. Structure (2010) 1.39

p63 steps into the limelight: crucial roles in the suppression of tumorigenesis and metastasis. Nat Rev Cancer (2013) 1.34

MiR-148a promotes apoptosis by targeting Bcl-2 in colorectal cancer. Cell Death Differ (2011) 1.33

TP53 and MTOR crosstalk to regulate cellular senescence. Aging (Albany NY) (2010) 1.32

Recent advances in p53 research and cancer treatment. J Biomed Biotechnol (2011) 1.31

p53 at the endoplasmic reticulum regulates apoptosis in a Ca2+-dependent manner. Proc Natl Acad Sci U S A (2015) 1.30

PUMA binding induces partial unfolding within BCL-xL to disrupt p53 binding and promote apoptosis. Nat Chem Biol (2013) 1.28

Targeting p53 for Novel Anticancer Therapy. Transl Oncol (2010) 1.26

Surf the post-translational modification network of p53 regulation. Int J Biol Sci (2012) 1.25

Small molecule induced reactivation of mutant p53 in cancer cells. Nucleic Acids Res (2013) 1.24

Apoptotic cell signaling in cancer progression and therapy. Integr Biol (Camb) (2011) 1.22

MicroRNA-34a upregulation during seizure-induced neuronal death. Cell Death Dis (2012) 1.20

The prolyl-isomerase Pin1 activates the mitochondrial death program of p53. Cell Death Differ (2012) 1.20

MiR-34 modulates Caenorhabditis elegans lifespan via repressing the autophagy gene atg9. Age (Dordr) (2011) 1.17

Review: Oxygen and trophoblast biology--a source of controversy. Placenta (2011) 1.16

How to control self-digestion: transcriptional, post-transcriptional, and post-translational regulation of autophagy. Trends Cell Biol (2015) 1.16

Regulation of glucose metabolism by p53: emerging new roles for the tumor suppressor. Oncotarget (2011) 1.15

In vivo analysis of p53 tumor suppressor function using genetically engineered mouse models. Carcinogenesis (2010) 1.14

Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA. J Biol Chem (2011) 1.13

The novel tryptamine derivative JNJ-26854165 induces wild-type p53- and E2F1-mediated apoptosis in acute myeloid and lymphoid leukemias. Mol Cancer Ther (2010) 1.11

Molecular mechanisms of natural killer cell activation in response to cellular stress. Cell Death Differ (2013) 1.11

p53-Reactivating small molecules induce apoptosis and enhance chemotherapeutic cytotoxicity in head and neck squamous cell carcinoma. Oral Oncol (2010) 1.10

Using mice to examine p53 functions in cancer, aging, and longevity. Cold Spring Harb Perspect Biol (2009) 1.10

Stem cells: balancing resistance and sensitivity to DNA damage. Trends Cell Biol (2014) 1.09

Inhibition of AMP-activated protein kinase α (AMPKα) by doxorubicin accentuates genotoxic stress and cell death in mouse embryonic fibroblasts and cardiomyocytes: role of p53 and SIRT1. J Biol Chem (2012) 1.08

Molecular mechanisms of neonatal brain injury. Neurol Res Int (2012) 1.07

Autophagy in pancreatic cancer pathogenesis and treatment. Am J Cancer Res (2012) 1.07

Autophagy and genomic integrity. Cell Death Differ (2013) 1.07

DNA damage strength modulates a bimodal switch of p53 dynamics for cell-fate control. BMC Biol (2013) 1.06

New insights into p53 activation. Cell Res (2010) 1.06

In vivo activation of the p53 tumor suppressor pathway by an engineered cyclotide. J Am Chem Soc (2013) 1.06

Beyond effector caspase inhibition: Bcl2L12 neutralizes p53 signaling in glioblastoma. Cell Cycle (2011) 1.06

Life or death: p53-induced apoptosis requires DNA binding cooperativity. Cell Cycle (2010) 1.05

Bax, Bcl2, and p53 differentially regulate neomycin- and gentamicin-induced hair cell death in the zebrafish lateral line. J Assoc Res Otolaryngol (2013) 1.05

Prostaglandin (PG)D(2) and 15-deoxy-Delta(12,14)-PGJ(2), but not PGE(2), mediate shear-induced chondrocyte apoptosis via protein kinase A-dependent regulation of polo-like kinases. Cell Death Differ (2010) 1.04

Heat shock protein 90-mediated inactivation of nuclear factor-κB switches autophagy to apoptosis through becn1 transcriptional inhibition in selenite-induced NB4 cells. Mol Biol Cell (2011) 1.04

SUMO-specific protease 2 in Mdm2-mediated regulation of p53. Cell Death Differ (2010) 1.04

TRIM16 acts as a tumour suppressor by inhibitory effects on cytoplasmic vimentin and nuclear E2F1 in neuroblastoma cells. Oncogene (2010) 1.04

Drosophila p53 isoforms differentially regulate apoptosis and apoptosis-induced proliferation. Cell Death Differ (2012) 1.02

Mechanism and preclinical prevention of increased breast cancer risk caused by pregnancy. Elife (2013) 1.02

The E3 ubiquitin ligase Mule acts through the ATM-p53 axis to maintain B lymphocyte homeostasis. J Exp Med (2012) 1.02

Induction of p53-mediated transcription and apoptosis by exportin-1 (XPO1) inhibition in mantle cell lymphoma. Cancer Sci (2014) 1.02

Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J Virol (2010) 1.01

Therapeutic targeting of the p53 pathway in cancer stem cells. Expert Opin Ther Targets (2012) 1.01

Cytoplasmic CUL9/PARC ubiquitin ligase is a tumor suppressor and promotes p53-dependent apoptosis. Cancer Res (2011) 1.00

p53 mediates cigarette smoke-induced apoptosis of pulmonary endothelial cells: inhibitory effects of macrophage migration inhibitor factor. Am J Respir Cell Mol Biol (2010) 1.00

Novel Insights into the Interplay between Apoptosis and Autophagy. Int J Cell Biol (2012) 1.00

Growth of peripheral and central nervous system tumors is supported by cytoplasmic c-Fos in humans and mice. PLoS One (2010) 1.00

Functions of B56-containing PP2As in major developmental and cancer signaling pathways. Life Sci (2010) 0.99

Mdm2 promotes systemic lupus erythematosus and lupus nephritis. J Am Soc Nephrol (2011) 0.99

p53: Pro-aging or pro-longevity? Aging (Albany NY) (2010) 0.98

Mitochondrial disulfide relay mediates translocation of p53 and partitions its subcellular activity. Proc Natl Acad Sci U S A (2013) 0.98

p53 and mitochondrial function in neurons. Biochim Biophys Acta (2014) 0.97

Prohibitin 1 modulates mitochondrial stress-related autophagy in human colonic epithelial cells. PLoS One (2012) 0.97

Regulation of mitochondrial apoptotic events by p53-mediated disruption of complexes between antiapoptotic Bcl-2 members and Bim. J Biol Chem (2010) 0.97

Heat stress induces apoptosis through transcription-independent p53-mediated mitochondrial pathways in human umbilical vein endothelial cell. Sci Rep (2014) 0.97

APR-246/PRIMA-1MET inhibits thioredoxin reductase 1 and converts the enzyme to a dedicated NADPH oxidase. Cell Death Dis (2013) 0.97

p53 Acetylation: Regulation and Consequences. Cancers (Basel) (2014) 0.97

PP2A:B56{epsilon}, a substrate of caspase-3, regulates p53-dependent and p53-independent apoptosis during development. J Biol Chem (2010) 0.96

Full p53 transcriptional activation potential is dispensable for tumor suppression in diverse lineages. Proc Natl Acad Sci U S A (2011) 0.95

Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J Biol Chem (2011) 0.95

Resveratrol inhibits the growth of gastric cancer by inducing G1 phase arrest and senescence in a Sirt1-dependent manner. PLoS One (2013) 0.95

bis-Dehydroxy-Curcumin triggers mitochondrial-associated cell death in human colon cancer cells through ER-stress induced autophagy. PLoS One (2013) 0.94

Selective killing of p53-deficient cancer cells by SP600125. EMBO Mol Med (2012) 0.94

Autophagy induced by deficiency of sphingosine-1-phosphate phosphohydrolase 1 is switched to apoptosis by calpain-mediated autophagy-related gene 5 (Atg5) cleavage. J Biol Chem (2011) 0.93

Silencing of mutant p53 by siRNA induces cell cycle arrest and apoptosis in human bladder cancer cells. World J Surg Oncol (2013) 0.93

Drosophila foxo acts in males to cause sexual-dimorphism in tissue-specific p53 life span effects. Exp Gerontol (2009) 0.93

ISG20L1 is a p53 family target gene that modulates genotoxic stress-induced autophagy. Mol Cancer (2010) 0.92

Regulated unfolding of proteins in signaling. FEBS Lett (2013) 0.92

Cross-talk between HIF and p53 as mediators of molecular responses to physiological and genotoxic stresses. Mol Cancer (2013) 0.91

Molecular mechanisms underlying chemical liver injury. Expert Rev Mol Med (2012) 0.91

Quercetin induces mitochondrial mediated apoptosis and protective autophagy in human glioblastoma U373MG cells. Oxid Med Cell Longev (2013) 0.91

Articles cited by this

Autophagy in the pathogenesis of disease. Cell (2008) 34.68

Mitochondrial membrane permeabilization in cell death. Physiol Rev (2007) 12.72

Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol (2008) 11.05

Role of autophagy in cancer. Nat Rev Cancer (2007) 10.88

Direct activation of Bax by p53 mediates mitochondrial membrane permeabilization and apoptosis. Science (2004) 9.52

DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell (2006) 9.47

p53 has a direct apoptogenic role at the mitochondria. Mol Cell (2003) 8.98

p53 target genes sestrin1 and sestrin2 connect genotoxic stress and mTOR signaling. Cell (2008) 6.88

BAX activation is initiated at a novel interaction site. Nature (2008) 6.07

Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97

Mitochondrial p53 activates Bak and causes disruption of a Bak-Mcl1 complex. Nat Cell Biol (2004) 5.56

PUMA couples the nuclear and cytoplasmic proapoptotic function of p53. Science (2005) 5.49

Diagnosing and exploiting cancer's addiction to blocks in apoptosis. Nat Rev Cancer (2008) 5.35

p53-dependent apoptosis in the absence of transcriptional activation of p53-target genes. Nature (1994) 4.77

Negative regulation of the deacetylase SIRT1 by DBC1. Nature (2008) 4.29

The common biology of cancer and ageing. Nature (2007) 4.28

GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation. Cell (2007) 4.22

Conversion of Bcl-2 from protector to killer by interaction with nuclear orphan receptor Nur77/TR3. Cell (2004) 4.00

A short mitochondrial form of p19ARF induces autophagy and caspase-independent cell death. Mol Cell (2006) 3.98

Induction of apoptosis in HeLa cells by trans-activation-deficient p53. Genes Dev (1995) 3.40

Discovery, in vivo activity, and mechanism of action of a small-molecule p53 activator. Cancer Cell (2008) 3.38

A complex barcode underlies the heterogeneous response of p53 to stress. Nat Rev Mol Cell Biol (2008) 3.13

SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization. Cell Stem Cell (2008) 2.67

Monoubiquitylation promotes mitochondrial p53 translocation. EMBO J (2007) 2.62

Small-molecule inhibitor of p53 binding to mitochondria protects mice from gamma radiation. Nat Chem Biol (2006) 2.47

p53's mitochondrial translocation and MOMP action is independent of Puma and Bax and severely disrupts mitochondrial membrane integrity. Cell Res (2008) 2.27

p53 and Nur77/TR3 - transcription factors that directly target mitochondria for cell death induction. Oncogene (2006) 2.04

Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle (2008) 2.03

Pharmacologic activation of p53 elicits Bax-dependent apoptosis in the absence of transcription. Cancer Cell (2003) 1.88

CP-31398 restores mutant p53 tumor suppressor function and inhibits UVB-induced skin carcinogenesis in mice. J Clin Invest (2007) 1.71

Mitochondrial p32 is a critical mediator of ARF-induced apoptosis. Cancer Cell (2008) 1.66

The effects of p53 on whole organism longevity are mediated by autophagy. Autophagy (2008) 1.63

Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain. J Biol Chem (2008) 1.55

ARF induces autophagy by virtue of interaction with Bcl-xl. J Biol Chem (2008) 1.45

Lack of correlation between p53-dependent transcriptional activity and the ability to induce apoptosis among 179 mutant p53s. Cancer Res (2005) 1.43

Regulation of p53 tetramerization and nuclear export by ARC. Proc Natl Acad Sci U S A (2007) 1.41

Regulation of transactivation-independent proapoptotic activity of p53 by FOXO3a. Proc Natl Acad Sci U S A (2006) 1.37

Comparative biophysical characterization of p53 with the pro-apoptotic BAK and the anti-apoptotic BCL-xL. J Biol Chem (2007) 1.23

Knockin mice expressing a chimeric p53 protein reveal mechanistic differences in how p53 triggers apoptosis and senescence. Proc Natl Acad Sci U S A (2008) 1.05

Mitochondrial translocation of p53 underlies the selective death of hippocampal CA1 neurons after global cerebral ischaemia. Biochem Soc Trans (2006) 1.02

The N-terminal domain of tumor suppressor p53 is involved in the molecular interaction with the anti-apoptotic protein Bcl-Xl. Biochem Biophys Res Commun (2006) 0.95

Articles by these authors

(truncated to the top 100)

Autophagy in the pathogenesis of disease. Cell (2008) 34.68

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Self-eating and self-killing: crosstalk between autophagy and apoptosis. Nat Rev Mol Cell Biol (2007) 15.47

The hallmarks of aging. Cell (2013) 14.29

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat Med (2007) 13.90

The pathophysiology of mitochondrial cell death. Science (2004) 13.87

Functional and physical interaction between Bcl-X(L) and a BH3-like domain in Beclin-1. EMBO J (2007) 11.72

Calreticulin exposure dictates the immunogenicity of cancer cell death. Nat Med (2006) 10.54

Inhibition of macroautophagy triggers apoptosis. Mol Cell Biol (2005) 10.27

Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol (2010) 9.06

Activation of the NLRP3 inflammasome in dendritic cells induces IL-1beta-dependent adaptive immunity against tumors. Nat Med (2009) 6.73

Immunological aspects of cancer chemotherapy. Nat Rev Immunol (2008) 6.61

Cancer despite immunosurveillance: immunoselection and immunosubversion. Nat Rev Immunol (2006) 6.13

Current development of mTOR inhibitors as anticancer agents. Nat Rev Drug Discov (2006) 5.99

Regulation of autophagy by cytoplasmic p53. Nat Cell Biol (2008) 5.97

Autophagy and aging. Cell (2011) 5.96

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science (2011) 5.62

Induction of autophagy by spermidine promotes longevity. Nat Cell Biol (2009) 5.00

Cell death by mitotic catastrophe: a molecular definition. Oncogene (2004) 4.75

Cell death by necrosis: towards a molecular definition. Trends Biochem Sci (2006) 4.67

The intestinal microbiota modulates the anticancer immune effects of cyclophosphamide. Science (2013) 4.60

Bcl-2 family members: dual regulators of apoptosis and autophagy. Autophagy (2008) 4.42

An immunosurveillance mechanism controls cancer cell ploidy. Science (2012) 4.35

Immunogenic and tolerogenic cell death. Nat Rev Immunol (2009) 4.34

Caspase-dependent immunogenicity of doxorubicin-induced tumor cell death. J Exp Med (2005) 4.32

Targeting mitochondria for cancer therapy. Nat Rev Drug Discov (2010) 4.07

The anticancer immune response: indispensable for therapeutic success? J Clin Invest (2008) 4.01

The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J Cell Sci (2005) 3.93

Targeted deletion of AIF decreases mitochondrial oxidative phosphorylation and protects from obesity and diabetes. Cell (2007) 3.82

Mitochondria and the autophagy-inflammation-cell death axis in organismal aging. Science (2011) 3.74

Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance. Immunity (2013) 3.73

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation. J Exp Med (2005) 3.64

The secret ally: immunostimulation by anticancer drugs. Nat Rev Drug Discov (2012) 3.60

Decoding cell death signals in inflammation and immunity. Cell (2010) 3.41

Immune parameters affecting the efficacy of chemotherapeutic regimens. Nat Rev Clin Oncol (2011) 3.41

Mitotic catastrophe: a mechanism for avoiding genomic instability. Nat Rev Mol Cell Biol (2011) 3.40

Anticancer chemotherapy-induced intratumoral recruitment and differentiation of antigen-presenting cells. Immunity (2013) 3.26

Does autophagy contribute to cell death? Autophagy (2005) 3.21

A novel dendritic cell subset involved in tumor immunosurveillance. Nat Med (2006) 3.21

Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle (2006) 3.21

AIF deficiency compromises oxidative phosphorylation. EMBO J (2004) 3.19

BH3-only proteins and BH3 mimetics induce autophagy by competitively disrupting the interaction between Beclin 1 and Bcl-2/Bcl-X(L). Autophagy (2007) 3.08

Alternatively spliced NKp30 isoforms affect the prognosis of gastrointestinal stromal tumors. Nat Med (2011) 3.03

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy. Immunol Rev (2007) 2.96

Stimulation of autophagy by the p53 target gene Sestrin2. Cell Cycle (2009) 2.72

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death. EMBO J (2009) 2.72

Platelet formation is the consequence of caspase activation within megakaryocytes. Blood (2002) 2.62

Necroptosis: a specialized pathway of programmed necrosis. Cell (2008) 2.61

Lysosomal membrane permeabilization induces cell death in a mitochondrion-dependent fashion. J Exp Med (2003) 2.56

Autophagy regulation by p53. Curr Opin Cell Biol (2010) 2.56

Can autophagy promote longevity? Nat Cell Biol (2010) 2.55

Cell death assays for drug discovery. Nat Rev Drug Discov (2011) 2.51

Apoptosis-inducing factor is involved in the regulation of caspase-independent neuronal cell death. J Cell Biol (2002) 2.47

The IKK complex contributes to the induction of autophagy. EMBO J (2009) 2.41

Fatty acids trigger mitochondrion-dependent necrosis. Cell Cycle (2010) 2.37

Complex inhibitory effects of nitric oxide on autophagy. Mol Cell (2011) 2.36

An AIF orthologue regulates apoptosis in yeast. J Cell Biol (2004) 2.33

Metabolic targets for cancer therapy. Nat Rev Drug Discov (2013) 2.32

Defining the critical hurdles in cancer immunotherapy. J Transl Med (2011) 2.32

Immunogenic tumor cell death for optimal anticancer therapy: the calreticulin exposure pathway. Clin Cancer Res (2010) 2.29

Mitochondria: master regulators of danger signalling. Nat Rev Mol Cell Biol (2012) 2.28

miR-181a and miR-630 regulate cisplatin-induced cancer cell death. Cancer Res (2010) 2.24

Spermidine and resveratrol induce autophagy by distinct pathways converging on the acetylproteome. J Cell Biol (2011) 2.23

Viral control of mitochondrial apoptosis. PLoS Pathog (2008) 2.21

Nonapoptotic role for Apaf-1 in the DNA damage checkpoint. Mol Cell (2007) 2.20

Prognostic and predictive impact of intra- and peritumoral immune infiltrates. Cancer Res (2011) 2.16

Cytoplasmic STAT3 represses autophagy by inhibiting PKR activity. Mol Cell (2012) 2.14

Alternative cell death mechanisms in development and beyond. Genes Dev (2010) 2.14

Mitochondrial membrane permeabilization is a critical step of lysosome-initiated apoptosis induced by hydroxychloroquine. Oncogene (2003) 2.09

Involvement of p38alpha in the mitotic progression of p53(-/-) tetraploid cells. Cell Cycle (2010) 2.08

Decoding cell death signals in liver inflammation. J Hepatol (2013) 2.05

To die or not to die: that is the autophagic question. Curr Mol Med (2008) 2.05

Contribution of IL-17-producing gamma delta T cells to the efficacy of anticancer chemotherapy. J Exp Med (2011) 2.04

Methods for the assessment of mitochondrial membrane permeabilization in apoptosis. Apoptosis (2007) 2.04

Mutant p53 protein localized in the cytoplasm inhibits autophagy. Cell Cycle (2008) 2.03

A comprehensive glossary of autophagy-related molecules and processes (2nd edition). Autophagy (2011) 2.02

A comprehensive glossary of autophagy-related molecules and processes. Autophagy (2010) 2.00

Methods for assessing autophagy and autophagic cell death. Methods Mol Biol (2008) 1.96

Chemotherapy and radiotherapy: cryptic anticancer vaccines. Semin Immunol (2010) 1.94

Role of the c subunit of the FO ATP synthase in mitochondrial permeability transition. Cell Cycle (2013) 1.94

Apoptosis and genomic instability. Nat Rev Mol Cell Biol (2004) 1.92

Anti- and pro-tumor functions of autophagy. Biochim Biophys Acta (2009) 1.92

Mitochondria, the killer organelles and their weapons. J Cell Physiol (2002) 1.92

Pharmacological manipulation of cell death: clinical applications in sight? J Clin Invest (2005) 1.91

Autophagy is required for the activation of NFκB. Cell Cycle (2012) 1.89

Apoptosis regulation in tetraploid cancer cells. EMBO J (2006) 1.89

High-mobility group box 1 is essential for mitochondrial quality control. Cell Metab (2011) 1.89

Immunogenic cancer cell death: a key-lock paradigm. Curr Opin Immunol (2008) 1.89

Trial Watch: Experimental Toll-like receptor agonists for cancer therapy. Oncoimmunology (2012) 1.88

A dual role of p53 in the control of autophagy. Autophagy (2008) 1.88

Apoptosis-inducing factor (AIF): key to the conserved caspase-independent pathways of cell death? J Cell Sci (2002) 1.88

Liver mitochondrial membrane crosslinking and destruction in a rat model of Wilson disease. J Clin Invest (2011) 1.86

Inflammasomes in carcinogenesis and anticancer immune responses. Nat Immunol (2012) 1.85

Mitochondrial membrane permeabilization in neuronal injury. Nat Rev Neurosci (2009) 1.85

Autophagic removal of micronuclei. Cell Cycle (2012) 1.85

Chemotherapy induces ATP release from tumor cells. Cell Cycle (2009) 1.83

Tumor cell death and ATP release prime dendritic cells and efficient anticancer immunity. Cancer Res (2010) 1.82

DNA binding is required for the apoptogenic action of apoptosis inducing factor. Nat Struct Biol (2002) 1.81

Mitotic catastrophe constitutes a special case of apoptosis whose suppression entails aneuploidy. Oncogene (2004) 1.79